Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Anika Therapeutics (ANIK) Asset Utilization Ratio (2016 - 2025)

Anika Therapeutics (ANIK) has disclosed Asset Utilization Ratio for 15 consecutive years, with 0.59 as the latest value for Q4 2025.

  • Quarterly Asset Utilization Ratio rose 7.58% to 0.59 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.59 through Dec 2025, up 7.58% year-over-year, with the annual reading at 0.57 for FY2025, 13.33% up from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.59 at Anika Therapeutics, down from 0.6 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.61 in Q2 2025, with the low at 0.33 in Q4 2022.
  • Average Asset Utilization Ratio over 5 years is 0.44, with a median of 0.41 recorded in 2021.
  • The sharpest move saw Asset Utilization Ratio fell 23.22% in 2023, then soared 71.04% in 2025.
  • Over 5 years, Asset Utilization Ratio stood at 0.42 in 2021, then dropped by 22.59% to 0.33 in 2022, then rose by 23.5% to 0.4 in 2023, then soared by 36.91% to 0.55 in 2024, then grew by 7.58% to 0.59 in 2025.
  • According to Business Quant data, Asset Utilization Ratio over the past three periods came in at 0.59, 0.6, and 0.61 for Q4 2025, Q3 2025, and Q2 2025 respectively.